leisure time -WSS

leisure time

author：fashion 2025-09-06 07:17:25 - browse：9934

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Mindstrong's demise and the future of mental health care

focus

WSS

How the first Native Hawaiian psychiatrist helped diversify medicine

As obesity drug market grows, telehealth companies court payers

Study: Spinal cord stimulation helps patients with paralysis walk again

How to make over

Republicans love RFK Jr. What's that tell us about health in 2024?

Mindstrong's demise and the future of mental health care

focus

leisure time

focus

Peter Hotez and the public health issue of online harassment

Hospital at home shows how to bring innovation to health care

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How the drug

What does generative AI mean for health care? We asked experts

FDA seeks to regulate lab

The cancer drug shortage isn’t new — and neither are the solutions

How the Dana

Guidelines to prevent youth baseball injuries need more muscle

Medicaid, Medicare dual

knowledge

Medicare drug price negotiation program allowed for now

Address the ethical violations that led to 'Three Identical Strangers'

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Data show record exodus of life scientists from academia

Ionis has late

Paxlovid should be available without a positive Covid test

leisure time

Wikipedia

entertainment

entertainment